Skip to main content
Year archive

PRESCIENT THERAPEUTICS LIMITED — 2019 filings

All 58 regulatory filings released by PRESCIENT THERAPEUTICS LIMITED (PTX) in 2019, sourced directly from the official regulator.

58 Filings
2019 Period
2019 filings (58)
Filing Released Lang
PTX-200 High Overall Response in Ph2a Breast Cancer trial 6 pages 166.5KB
Regulatory Filings
2019-12-22 English
Release of Securities from Escrow 2 pages 136.2KB
Capital/Financing Update
2019-12-17 English
Ceasing to be a substantial holder 3 pages 185.9KB
Major Shareholding Notification
2019-12-12 English
Encouraging data from PTX-200 ovarian cancer trial 3 pages 160.9KB
Regulatory Filings
2019-12-11 English
Becoming a substantial holder 6 pages 215.6KB
Major Shareholding Notification
2019-12-01 English
Third complete response in PTX-200 AML Trial 3 pages 143.0KB
Regulatory Filings
2019-11-26 English
Response to ASX Price Query 4 pages 637.8KB
Regulatory Filings
2019-11-21 English
AGM Presentation 14 pages 1.3MB
AGM Information
2019-11-18 English
Results of Annual General Meeting 2 pages 230.5KB
Declaration of Voting Results & Voting Rights Announcements
2019-11-18 English
PTX in new CAR-T collaboration 5 pages 158.9KB
Regulatory Filings
2019-11-17 English
1st patient dosed in trial for first in class drug PTX-100 4 pages 138.3KB
Regulatory Filings
2019-11-13 English
Receipt of R&D Tax Rebate 3 pages 129.4KB
Regulatory Filings
2019-11-07 English
Ceasing to be a substantial holder 3 pages 120.4KB
Major Shareholding Notification
2019-11-05 English
Prescient Ausbiotech Ras Presentation 15 pages 1.6MB
Investor Presentation
2019-10-30 English
September 2019 Appendix 4C - Quarterly 9 pages 251.0KB
Interim / Quarterly Report
2019-10-29 English
Notice of Annual General Meeting/Proxy Form 17 pages 400.0KB
Proxy Solicitation & Information Statement
2019-10-15 English
Appendix 4E and 2019 Annual Report 62 pages 1.3MB
Annual Report
2019-08-25 English
Appendix 4G and Corporate Governance Statement 23 pages 412.0KB
Regulatory Filings
2019-08-25 English
Securities Trading Policy 6 pages 175.8KB
Governance Information
2019-08-21 English
June 2019 Appendix 4C - Quarterly 9 pages 204.7KB
Interim / Quarterly Report
2019-07-23 English
PTX Initiates Phase 1b Clinical Trial for PTX-100 4 pages 162.6KB
Regulatory Filings
2019-07-10 English
Ceasing to be a substantial holder 2 pages 78.4KB
Major Shareholding Notification
2019-06-13 English
Change in substantial holding 2 pages 108.4KB
Major Shareholding Notification
2019-06-11 English
Becoming a substantial holder 3 pages 183.0KB
Major Shareholding Notification
2019-06-10 English
Change in substantial holding 6 pages 1.2MB
Major Shareholding Notification
2019-06-10 English
Appendix 3B 12 pages 274.4KB
Share Issue/Capital Change
2019-06-02 English
Change to Exercise Price of Options 2 pages 108.6KB
Capital/Financing Update
2019-05-29 English
Prescient to present at Sydney Conference 2 pages 106.8KB
Investor Presentation
2019-05-20 English
Investor Presentation - May 2019 19 pages 1.1MB
Investor Presentation
2019-05-20 English
Canadian Patent Granted for PTX-200 2 pages 105.8KB
Regulatory Filings
2019-05-15 English
Becoming a substantial holder 4 pages 145.8KB
Regulatory Filings
2019-05-07 English
Ceasing to be a substantial holder 1 page 33.3KB
Regulatory Filings
2019-05-06 English
Change of Director's Interest Notices x4 11 pages 156.9KB
Director's Dealing
2019-05-05 English
Completion of Capital Raising, S708A Notice and Appendix 3B 15 pages 288.1KB
Capital/Financing Update
2019-05-02 English
Becoming a substantial holder 2 pages 61.4KB
Regulatory Filings
2019-05-01 English
Completion of Entitlement Offer Allotment & Appendix 3B 14 pages 288.6KB
Capital/Financing Update
2019-04-29 English
Entitlement Offer Results and Shortfall Notification 2 pages 130.0KB
Capital/Financing Update
2019-04-25 English
Results of Meeting 2 pages 324.3KB
Declaration of Voting Results & Voting Rights Announcements
2019-04-25 English
March 2019 Appendix 4C - Quarterly 8 pages 382.2KB
Interim / Quarterly Report
2019-04-23 English
Change in substantial holding 3 pages 309.1KB
Major Shareholding Notification
2019-04-09 English
Ceasing to be a substantial holder 2 pages 57.3KB
Regulatory Filings
2019-04-02 English
Despatch of Entitlement Offer Documents 49 pages 698.1KB
Capital/Financing Update
2019-04-02 English
Section 708A Cleansing Notice and Appendix 3B 16 pages 370.2KB
Share Issue/Capital Change
2019-03-31 English
Amended Appendix 3B - Rights Issue 15 pages 685.4KB
Capital/Financing Update
2019-03-26 English
Notice of General Meeting/Proxy Form 14 pages 361.5KB
Proxy Solicitation & Information Statement
2019-03-26 English
Change of Director's Interest Notice - J Campbell 2 pages 41.9KB
Director's Dealing
2019-03-25 English
Prescient Completes Equity Raising to Raise $9.1 Million 6 pages 237.7KB
Capital/Financing Update
2019-03-24 English
Capital Raising Presentation - March 2019 36 pages 1.4MB
Capital/Financing Update
2019-03-24 English
Prospectus 47 pages 611.1KB
Capital/Financing Update
2019-03-24 English
Appendix 3B - Rights Issue 12 pages 182.5KB
Capital/Financing Update
2019-03-24 English
Letter to Eligible Shareholders 3 pages 89.6KB
Capital/Financing Update
2019-03-24 English
Letter to Ineligible shareholders 2 pages 110.3KB
Capital/Financing Update
2019-03-24 English
Letter to Optionholders 2 pages 107.7KB
Capital/Financing Update
2019-03-24 English
Trading Halt 2 pages 376.3KB
Capital/Financing Update
2019-03-20 English
Investor Presentation - February 2019 18 pages 1.1MB
Investor Presentation
2019-02-24 English
Appendix 4D and Half Year Financial Report 23 pages 604.8KB
Interim / Quarterly Report
2019-02-20 English
December 2018 Appendix 4C - Quarterly 8 pages 158.0KB
Interim / Quarterly Report
2019-01-30 English
Receipt of R&D Tax Rebate 2 pages 117.5KB
Regulatory Filings
2019-01-14 English